Get started
222

PHARMARESEARCH BIO

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

217950 chart


Full chart

Key stats


Market capitalization
‪128.56 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪2.31 B‬ KRW
Revenue (FY)
‪20.03 B‬ KRW
Shares float
‪2.03 M‬
Beta (1Y)
0.80

Employees


Employees (FY)
78
Change (1Y)
+8 +11.43%
Revenue / Employee (1Y)
‪197.22 K‬ KRW
Net income / Employee (1Y)
‪22.73 K‬ KRW

About PHARMARESEARCH BIO


Sector
Health Technology
Industry
Biotechnology
Headquarters
Gangneung-si
Website
pr-bio.co.kr
Founded
2009
ISIN
KR7217950005
FIGI
BBG00BC1M512
PHARMARESEARCH BIO Co., Ltd. engages in the development and distribution of biopharmaceutical products. Its products include Clostridium botulinum toxin type A. The company was founded on October 29, 2009 and is headquartered in Gangneung-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 217950 is 31,650 KRW — it has decreased by −1.71% in the past 24 hours. Watch PHARMARESEARCH BIO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMARESEARCH BIO stocks are traded under the ticker 217950.
217950 stock has fallen by −2.91% compared to the previous week, the month change is a −13.05% fall, over the last year PHARMARESEARCH BIO has showed a 52.53% increase.
217950 reached its all-time high on Jan 13, 2022 with the price of 45,000 KRW, and its all-time low was 6,150 KRW and was reached on Oct 7, 2019. View more price dynamics on 217950 chart.
See other stocks reaching their highest and lowest prices.
217950 stock is 5.69% volatile and has beta coefficient of 0.80. Track PHARMARESEARCH BIO stock price on the chart and check out the list of the most volatile stocks — is PHARMARESEARCH BIO there?
Today PHARMARESEARCH BIO has the market capitalization of ‪128.56 B‬, it has decreased by −2.28% over the last week.
Yes, you can track PHARMARESEARCH BIO financials in yearly and quarterly reports right on TradingView.
No, 217950 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 78.00 employees. See our rating of the largest employees — is PHARMARESEARCH BIO on this list?
Like other stocks, 217950 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARESEARCH BIO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMARESEARCH BIO technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMARESEARCH BIO stock shows the buy signal. See more of PHARMARESEARCH BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.